Pregled bibliografske jedinice broj: 1125288
New generation of vaccines - mRNA vaccines as the most promising tool against the COVID-19 pandemic
New generation of vaccines - mRNA vaccines as the most promising tool against the COVID-19 pandemic // Pandemic the new normal
Osijek, Hrvatska, 2021. str. 92-92 (poster, podatak o recenziji nije dostupan, sažetak, ostalo)
CROSBI ID: 1125288 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
New generation of vaccines - mRNA vaccines as
the most promising tool against the COVID-19
pandemic
Autori
Janić ; Ivana ; Jukić, Marijana ; Glavaš-Obrovac, Ljubica
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Pandemic the new normal
/ - , 2021, 92-92
ISBN
978-953-7736-48-4
Skup
3rd International Translational Medicine Congress Of Students And Young Physicians
Mjesto i datum
Osijek, Hrvatska, 19.03.2021. - 20.03.2021
Vrsta sudjelovanja
Poster
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
mRNA, vaccines, SARS-CoV-2
Sažetak
Introduction: The COVID-19 pandemic and the urgent need to develop a vacci ne against SARS-CoV-2 have accelerated the development of the mRNA technology, which was already shown to be promising because of its rapid development, high-potency, low-cost manufacturing, and safe administration. The aim of this review is to present current mRNA vaccine fi ndings , to point out challenges and recent successes, as well as to offer a perspective on the future of mRNA vaccines. Review: Current research of the RNA-based vacci nes is usually divided between two platforms, depending on the RNA used for the vaccine: a non-replicating mRNA and a virally derived, selfamplifying, RNA (saRNA). While both types encode the antigen of interest, the saRNA also encodes the viral replication machinery. Until recently, the mRNA vaccine development has been limited by the mRNA instability and inefficient in vivo delivery. Today, there are two basic approaches to the mRNA vaccine delivery that have been described. The firs t approach amounts to loadi ng of the mRNA into the patient's dendri tic cells ex vivo. This approach has greater precision and efficacy, but it is both timeconsuming and labour-intensive. The second approach, which has garnered a lot of attention lately, involves a direct parenteral injection of the mRNA with or without a carrier, thus greatly simplifying the vaccine delivery and enabling costeffective mass vaccination. Conclusion: COVID-19 pandemic has shown that the mRNA-based vaccines are one of the most promising public health tools for quickly responding to a novel pandemic infectious disease.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Integrativna bioetika (prirodne, tehničke, biomedicina i zdravstvo, biotehničke, društvene, humanističke znanosti)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Osijek